Effect of a synbiotic on the response to seasonal influenza vaccination is strongly influenced by degree of immunosenescence

Immunity and Ageing

Volumn 13, Issue 1, 2016, Pages

  Przemska Kosicka, Agnieszka ^a   Childs, Caroline E ^a   Enani, Sumia ^a   Maidens, Catherine ^a   Dong, Honglin ^a   Dayel, Iman Bin ^a   Tuohy, Kieran ^b   Todd, Susan ^a   Gosney, Margot A ^a   Yaqoob, Parveen ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b RESEARCH AND INNOVATION CENTRE   (Italy)

Author keywords

Ageing; Influenza; Prebiotic; Probiotic; Vaccination

Indexed keywords

CD28 ANTIGEN; CD57 ANTIGEN; CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INFLUENZA VACCINE; PLACEBO; PROBIOTIC AGENT PLUS GLUCO OLIGOSACCHARIDE; SYNBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BIFIDOBACTERIUM INFANTIS; COHORT ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FECES ANALYSIS; FEMALE; HELPER CELL; HUMAN; IMMUNOMODULATION; IMMUNOSENESCENCE; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA VACCINATION; LYMPHOCYTE COUNT; MALE; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRIORITY JOURNAL; PROTECTION; RANDOMIZED CONTROLLED TRIAL; SEASONAL INFLUENZA; SEROCONVERSION;

EID: 84961188883     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/s12979-016-0061-4     Document Type: Article

References (36)

1. Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol. 2014;29:38-42.
2. Pang IK, Iwasaki A. Inflammasomes as mediators of immunity against influenza virus. Trends Immunol. 2011;32:34-41.
3. Pang IK, Iwasaki A. Control of antiviral immunity by pattern recognition and the microbiome. Immunol Rev. 2012;245:209-26.
4. Hao Q, Lu Z, Dong BR et al. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. 2011:CD006895. doi: 10.1002/14651858.CD006895.pub2.
5. MacDonald TT, Bell I. Probiotics and the immune response to vaccines. Proc Nutr Soc. 2010;69:442-6.
6. Maidens C, Childs C, Przemska A, et al. Modulation of vaccine response by concomitant probiotic administration. Br J Clin Pharmacol. 2013;75:663-70.
7. Lomax AR, Calder PC. Prebiotics, immune function, infection and inflammation: a review of the evidence. Br J Nutr. 2009;101:633-58.
8. Biagi E, Candela M, Turroni S, et al. Ageing and gut microbes: perspectives for health maintenance and longevity. Pharmacol Res. 2013;69:11-20.
9. Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology. 2011;140:1713-9.
10. Silvi S, Verdenelli MC, Orpianesi C, Cresci A. EU project Crownalife: functional foods, gut microflora and healthy ageing - Isolation and identification of Lactobacillus and Bifidobacterium strains from faecal samples of elderly subjects for a possible probiotic use in functional foods. J Food Eng. 2003;56:195-200.
11. Likotrafiti EMKSF, F.; Tuohy, K.M.; Gibson, G.R.; Rastall, R.A. Molecular identification and anti-pathogenic activities of putative probiotic bacteria isolated from faeces of healthy elderly adults. Microbial Ecology in Health and Disease 2004; 16:8.
12. You J, Yaqoob P. Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486. FEMS Immunol Med Microbiol. 2012;66:353-62.
13. Derhovanessian E, Pawelec G. Vaccination in the elderly. Microb Biotechnol. 2012;5:226-32.
14. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: A quantitative review. Vaccine. 2006;24:1159-69.
15. Yaqoob P. Ageing, immunity and influenza: a role for probiotics? Proc Nutr Soc. 2014;73:309-17.
16. Kovaiou RD, Herndler-Brandstetter D, Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med. 2007;9:1-17.
17. Bunout D, Barrera G, Hirsch S, et al. Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. JPEN J Parenter Enteral Nutr. 2004;28:348-54.
18. Boge T, Remigy M, Vaudaine S, et al. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine. 2009;27:5677-84.
19. Namba K, Hatano M, Yaeshima T, et al. Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly. Biosci Biotechnol Biochem. 2010;74:939-45.
20. Van Puyenbroeck K, Hens N, Coenen S, et al. Efficacy of daily intake of Lactobacillus casei Shirota on respiratory symptoms and influenza vaccination immune response: a randomized, double-blind, placebo-controlled trial in healthy elderly nursing home residents. Am J Clin Nutr. 2012;95:1165-71.
21. Isolauri E, Joensuu J, Suomalainen H, et al. Improved Immunogenicity of Oral Dxrrv Reassortant Rotavirus Vaccine by Lactobacillus-Casei Gg. Vaccine. 1995;13:310-2.
22. de Vrese M, Winkler P, Rautenberg P, et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine. 2006;24:6670-4.
23. Olivares M, Diaz-Ropero MP, Sierra S, et al. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition. 2007;23:254-60.
24. Bosch M, Mendez M, Perez M, et al. Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly. Nutricion hospitalaria: organo oficial de la Sociedad Espanola de Nutricion Parenteral y Enteral. 2012;27:504-9.
25. Rizzardini G, Eskesen D, Calder PC, et al. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12(R) and Lactobacillus paracasei ssp. paracasei, L. casei 431(R) in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br J Nutr. 2012;107:876-84.
26. You J, Dong H, Mann ER, et al. Ageing impairs the T cell response to dendritic cells. Immunobiology. 2013;218:1077-84.
27. Likotrafiti E, Manderson KS, Fava F, Tuohy KM, Gibson GR, Rastall RA. Molecular identification and anti-pathogenic activities of putative probiotic bacteria isolated from faeces of healthy elderly individuals. Microb Ecol Health Dis. 2004;16:105-12.
28. Vallejo AN. Immune remodeling: lessons from repertoire alterations during chronological aging and in immune-mediated disease. Trends Mol Med. 2007;13:94-102.
29. Derhovanessian E, Maier AB, Hahnel K, et al. Latent Infection with Cytomegalovirus Is Associated with Poor Memory CD4 Responses to Influenza A Core Proteins in the Elderly. J Immunol. 2014;193:3624-31.
30. Frei R, Akdis M, O'Mahony L. Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr Opin Gastroen. 2015;31:153-8.
31. Ligthart GJ, Corberand JX, Fournier C, et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev. 1984;28:47-55.
32. Hudon C, Fortin A, Vanasse A. Cumulative Illness Rating Scale was a reliable and valid index in a family practice context. J Clin Epidemiol. 2005;58:603-8.
33. Davidson LE, Fiorino AM, Snydman DR, Hibberd PL. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr. 2011;65:501-7.
34. Sarbini SR, Kolida S, Gibson GR, Rastall RA. In vitro fermentation of commercial alpha-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. Br J Nutr. 2013;109:1980-9.
35. Kang M, Ragan BG, Park JH. Issues in outcomes research: an overview of randomization techniques for clinical trials. J Athl Train. 2008;43:215-21.
36. Costabile A, Kolida S, Klinder A, et al. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. British J Nutr. 2010;104:1007-17.